Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Krishan Taneja
Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-Dm1 in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
Expression Profile of BCL-2, BCL-XL, and McL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
BCL-Xl Down-Regulation Suppresses the Tumorigenic Potential of NPM/ALK in Vitro and in Vivo
Blood
Biochemistry
Immunology
Cell Biology
Hematology
BCL-xL in Neuroprotection and Plasticity
Frontiers in Physiology
Physiology
The BCL-2 Proteins Noxa and BCL-xL Co-Ordinately Regulate Oxidative Stress-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Crystal Structure of ABT-737 Complexed With BCL-xL: Implications for Selectivity of Antagonists of the BCL-2 Family
Cell Death and Differentiation
Cell Biology
Molecular Biology
Apoptosis Is Augmented in High-Grade Serous Ovarian Cancer by the Combined Inhibition of BCL-2/BCL-xL and PARP
International Journal of Oncology
Cancer Research
Oncology
Expression of Beclin-1, BCL-2, BCL-xL, Bad, and Bax in HCV Patients in Relation to Grade of Hepatic Fibrosis
Archives of Infectious Diseases & Therapy
